FR2358144A1 - Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire - Google Patents
Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaireInfo
- Publication number
- FR2358144A1 FR2358144A1 FR7621376A FR7621376A FR2358144A1 FR 2358144 A1 FR2358144 A1 FR 2358144A1 FR 7621376 A FR7621376 A FR 7621376A FR 7621376 A FR7621376 A FR 7621376A FR 2358144 A1 FR2358144 A1 FR 2358144A1
- Authority
- FR
- France
- Prior art keywords
- compsn
- hymecromone
- chenodeoxy
- treating
- lower cost
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 title abstract 4
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 title abstract 2
- 208000015924 Lithiasis Diseases 0.000 title abstract 2
- 229960001091 chenodeoxycholic acid Drugs 0.000 title abstract 2
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 title abstract 2
- 229960001396 hymecromone Drugs 0.000 title abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 210000000013 bile duct Anatomy 0.000 abstract 1
- 201000001883 cholelithiasis Diseases 0.000 abstract 1
- 230000001989 choleretic effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 210000001198 duodenum Anatomy 0.000 abstract 1
- 208000001130 gallstones Diseases 0.000 abstract 1
- 239000007903 gelatin capsule Substances 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- -1 polyoxyethylene Polymers 0.000 abstract 1
- 239000007901 soft capsule Substances 0.000 abstract 1
- 230000002048 spasmolytic effect Effects 0.000 abstract 1
- 210000004514 sphincter of oddi Anatomy 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7621376A FR2358144A1 (fr) | 1976-07-13 | 1976-07-13 | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire |
| DE19772700085 DE2700085A1 (de) | 1976-07-13 | 1977-01-04 | Arzneimittel |
| NZ184623A NZ184623A (en) | 1976-07-13 | 1977-07-11 | Pharmaceutical composition for treatment of billiary lithiasis |
| IL52502A IL52502A (en) | 1976-07-13 | 1977-07-11 | Pharmaceutical compositions for treating bile stones, comprising chenodeoxycholic acid |
| ZA00774164A ZA774164B (en) | 1976-07-13 | 1977-07-11 | Novel medicinal composition for the treatment of biliary lithiasis |
| IE1445/77A IE45303B1 (en) | 1976-07-13 | 1977-07-12 | Composition for treating biliary lithiasis |
| BE179283A BE856740A (fr) | 1976-07-13 | 1977-07-12 | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire |
| AU26953/77A AU2695377A (en) | 1976-07-13 | 1977-07-12 | Medicinal composition for the treatment of biliary lithiasis |
| GB29514/77A GB1541165A (en) | 1976-07-13 | 1977-07-13 | Composition for treating biliary lithiasis |
| JP8307577A JPS5312427A (en) | 1976-07-13 | 1977-07-13 | Treating agent for galllstone disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7621376A FR2358144A1 (fr) | 1976-07-13 | 1976-07-13 | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2358144A1 true FR2358144A1 (fr) | 1978-02-10 |
| FR2358144B1 FR2358144B1 (enExample) | 1978-12-15 |
Family
ID=9175646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7621376A Granted FR2358144A1 (fr) | 1976-07-13 | 1976-07-13 | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE856740A (enExample) |
| DE (1) | DE2700085A1 (enExample) |
| FR (1) | FR2358144A1 (enExample) |
| ZA (1) | ZA774164B (enExample) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2453649A1 (fr) * | 1978-12-15 | 1980-11-07 | Lehner Ag | Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs |
| EP0065666A1 (en) * | 1981-05-21 | 1982-12-01 | ERREGIERRE S.p.A. | Salts of cholic acids, process for their preparation and therapeutic compositions containing them as active principles |
| EP0509335A1 (en) * | 1991-04-12 | 1992-10-21 | ALFA WASSERMANN S.p.A. | Gastroresistant pharmaceutical formulations for oral administration containing bile acids |
| EP0510404A1 (en) * | 1991-04-12 | 1992-10-28 | ALFA WASSERMANN S.p.A. | Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| WO1994025014A1 (en) * | 1993-04-23 | 1994-11-10 | George Henry Wright | Management of cholelithiasis with beta-2-agonists |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ211078A (en) * | 1984-03-19 | 1987-08-31 | Bristol Myers Co | Oral dosage form of etoposide |
| DE3611467A1 (de) * | 1986-04-05 | 1987-10-08 | Dolorgiet Gmbh & Co Kg | Hochresorbierbare zubereitungsform des hymecromons und verfahren zur herstellung derselben |
| AT392906B (de) * | 1987-10-08 | 1991-07-10 | Hoffmann La Roche | Pharmazeutische praeparate zur oralen verabreichung |
-
1976
- 1976-07-13 FR FR7621376A patent/FR2358144A1/fr active Granted
-
1977
- 1977-01-04 DE DE19772700085 patent/DE2700085A1/de not_active Withdrawn
- 1977-07-11 ZA ZA00774164A patent/ZA774164B/xx unknown
- 1977-07-12 BE BE179283A patent/BE856740A/xx not_active IP Right Cessation
Non-Patent Citations (1)
| Title |
|---|
| NEANT * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2453649A1 (fr) * | 1978-12-15 | 1980-11-07 | Lehner Ag | Composition pharmaceutique a action prolongee contenant des acides biliaires utile notamment pour la lyse des calculs |
| EP0065666A1 (en) * | 1981-05-21 | 1982-12-01 | ERREGIERRE S.p.A. | Salts of cholic acids, process for their preparation and therapeutic compositions containing them as active principles |
| EP0509335A1 (en) * | 1991-04-12 | 1992-10-21 | ALFA WASSERMANN S.p.A. | Gastroresistant pharmaceutical formulations for oral administration containing bile acids |
| EP0510404A1 (en) * | 1991-04-12 | 1992-10-28 | ALFA WASSERMANN S.p.A. | Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids |
| WO1994025014A1 (en) * | 1993-04-23 | 1994-11-10 | George Henry Wright | Management of cholelithiasis with beta-2-agonists |
Also Published As
| Publication number | Publication date |
|---|---|
| ZA774164B (en) | 1978-05-30 |
| BE856740A (fr) | 1978-01-12 |
| FR2358144B1 (enExample) | 1978-12-15 |
| DE2700085A1 (de) | 1978-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0136011A3 (en) | A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor | |
| DE2967049D1 (en) | Pharmaceutical and dietary composition comprising gamma-linolenic acids | |
| DE2961102D1 (en) | Pharmaceutical and dietary composition comprising gamma-linolenic acids | |
| NO940277L (no) | Triglycerider og blandinger av slike | |
| IL56991A (en) | 4-halo-3-oxoandrost-4-ene-17 beta-thiocarboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
| DE59812646D1 (de) | Laminare Arzneiform | |
| IE801534L (en) | Gall-stone dissolution compositions. | |
| NO922936L (no) | Fremstilling av fettsyremedikamenter | |
| FR2358144A1 (fr) | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire | |
| PH18822A (en) | Sugar containing pharmaceutical preparations having low water content and process fo manufacture | |
| AU563273B2 (en) | Composition containing an essential fatty acid and niacin and/or a bile salt binder | |
| PH13213A (en) | Retinoic acid esters of steroids of the pregnone series,their use in the treatment of acne and pharmaceutical formulations useful therefor | |
| FR2377199A2 (fr) | Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire | |
| DE3172570D1 (en) | Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells | |
| ZA784083B (en) | Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions | |
| JPS5350316A (en) | Drug composition for oral administration | |
| DE3470534D1 (en) | Diniflumate of morpholinoethyl ester of niflumic acid, its preparation, and its use in analgesic and antiinflammatory pharmaceutical compositions | |
| IL85776A (en) | Pharmaceutical compositions comprising certain selenium containing algae and c18-c22 unsaturated acids and their preparation,used for treating conditions of the heart and cardiovascular system | |
| PH15995A (en) | 1-naphtyl acetic acid derivatives and their therapeutic composition | |
| EP0222099A3 (en) | Alpha-(aminoalkyl)-arylacetic acid derivatives | |
| JPS57122068A (en) | N-pyrimidinyl-carbamic acid ester, manufacture and medicine containing same | |
| KR880010762A (ko) | 소화성궤양의 치료방법 및 치료용 합성물(Composition and Method for Treatment of peptic Ulcers) | |
| ATE36333T1 (de) | Hydantoin enthaltende therapeutische mittel. | |
| DE2963782D1 (en) | Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation | |
| JPS6442470A (en) | Guanidinecarboxylic acid esters, manufacture and medicinal composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |